'
The related resources bookmark allows you to jump directly to other pages on the site that contain information directly related to the topics you're currently exploring.
- Home Page
- What's New?
- Tumor Types
- Molecular Causes of Cancer
- Biological Pathways
- Therapeutic Targets
- Pipeline Molecules
- Research Education
- Research ADCs
- Research Apoptosis
- Research B cell
- Research BRAF
- Research Cancer Immunotherapy
- Research HDIs
- Research HER Pathways
- Research MET
- Research VEGF
- Why is the VEGF ligand essential throughout tumor development?
- What are the strategies for inhibiting the VEGF pathway?
- What are the effects of direct VEGF ligand inhibition?
- Why is continued VEGF inhibition important?
- Why do tumors progress?
- The role of VEGF across tumor types
- Slide decks and videos
- Glossary
- Clinical Trials
- Resources
- Contact Us
Related Resources for this page:
Share
VEGF and Prognosis in Bladder Cancer
Several studies have shown that vascular endothelial growth factor (VEGF) is a prognostic factor in superficial bladder cancer, as serum levels of VEGF are associated with tumor activity.1,2
For more specific information on activity related to VEGF expression, click on the links below.
In This Section
References:
- 1.
- Crew JP, O'Brien T, Bradburn M, et al. Cancer Res. 1997;57:5281-5285. PMID: 9393750
- 2.
- Bernardini S, Fauconnet S, Chabannes E, et al. J Urol. 2001;166:1275-1279. PMID: 11547057